Leon von der Emde, Carl Zeiss Meditec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Maximilian Pfau, Carl Zeiss Meditec (F), CenterVue (F), Heidelberg Engineering (F), Novartis (F), Optos (F);
Chantal Dysli, Carl Zeiss Meditec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Sarah Thiele, Carl Zeiss Meditec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Sandrine Künzel, Carl Zeiss Meditec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Philipp Möller, Carl Zeiss Meditec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F);
Matthias Schmid, Bayer (C), Galimedix (C);
Monika Fleckenstein, Alcon/Novartis (F), Alcon/Novartis (C), Bayer Healthcare (F), Bayer Healthcare (R), Carl Zeiss Meditec (F), CenterVue (F), Genentech (F), Genentech (R), Genentech (C), Heidelberg Engineering (F), Heidelberg Engineering (R), Optos (F), US20140303013 (P);
Frank Holz, Acucela (C), Acucela (F), Allergan (F), Allergan (R), Appelis (C), Appelis (R), Bayer (C), Bayer (F), Bioeg/Formycon (C), Boehringer-Ingelheim (C), Carl Zeiss Meditec (F), CenterVue (F), Ellex (R), Geuder (C), Grayburg Vision (C), Heidelberg Engineering (F), LinBioscience (C), NightstarX (F), Novartis (C), Optos (F), Oxurion (C), Pixium vision (C), Roche/Genentech (C), Roche/Genentech (R), Stealth BioTherapeutics (C);
Steffen Schmitz-Valckenberg, Acuela (F), Alcon/Novartis (C), Alcon/Novartis (F), Alcon/Novartis (R), Allergan (C), Allergan (F), Allergan (R), Bayer (F), Bayer (R), Bioeg/Formycon (F), Bioeg/Formycon (C), Carl Zeiss Meditec (F), Carl Zeiss Meditec (R), CenterVue (F), Galimedix (C), Genentech/Roche (F), Genentech/Roche (R), Heidelberg Engineering (F), Katairo (F), Optos (F)